By Gerald Litwack
First released in 1943, Vitamins and Hormones is the longest-running serial released by way of educational Press. The Editorial Board now displays services within the box of hormone motion, diet motion, X-ray crystal constitution, body structure, and enzyme mechanisms.
Under the able and certified editorial management of Dr. Gerald Litwack, Vitamins and Hormones keeps to post state of the art studies of curiosity to endocrinologists, biochemists, nutritionists, pharmacologists, mobile biologists, and molecular biologists. Others attracted to the constitution and serve as of biologically lively molecules like hormones and supplements will, as regularly, flip to this sequence for entire stories by way of top participants to this and similar disciplines.
This quantity makes a speciality of activins and inhibins.
Read Online or Download Activins and Inhibins PDF
Best endocrinology & metabolism books
The interdisciplinary paintings revealing assorted roles in organic methods of continual ailments has resulted in a brand new box of study touching on universal molecular and medical positive aspects of continual illnesses. Epidemiological literature indicates an organization among the heritage of metabolic syndrome/diabetes mellitus variety 2 and the chance of constructing various cancers.
During this e-book, Harold Morowitz offers a brand new conception at the beginning of lifestyles on the earth 4 billion years in the past. Morowitz postulates that step one towards the starting place of lifestyles used to be the spontaneous condensation of amphiphilic molecules to shape vesicles or protocells. This speculation offers a framework for reexamining the emergence of cellularity.
A realistic "how to" advisor for a number of equipment in metabolism, with a serious and goal dialogue of strengths, boundaries, and applicable functions of the defined tools. Edited by way of the winner of the Oskar-Minkowski Prize of the EASD in 2006 medical trials in populations liable to or with overt diabetes mellitus are being played everywhere in the international to check novel medicinal drugs and techniques to handling those ailments.
This built-in scientific reference deals candid assurance and proficient perspectives on thyroid functionality and sickness. rigorously exact line drawings elucidate the discussions via three popular clinicians. assurance comprises thyroid hormone biosynthesis, laboratory overview, unhazardous goiter, hyperthyroidism, thyroid ailment in being pregnant, malignant illnesses, thyroiditis, and masses extra
- Molecular Endocrinology, Third Edition
- Iron Metabolism: From Molecular Mechanisms to Clinical Consequences
- Type 1 Diabetes in Adults
- Clinical Management of Overweight and Obesity: Recommendations of the Italian Society of Obesity (SIO)
Extra info for Activins and Inhibins
1992). Cloning and sequencing of a rat type II activin receptor. FEBS Lett. 312, 53–56. Shore, E. , Feldman, G. , Fenstermacher, D. , Cho, T. , Choi, I. , Connor, J. , Glaser, D. , Rogers, J. , et al. (2006). A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525–527. , and Tsuchida, K. (2000). Activin and follistatin. In “Skeletal Growth Factor,” (E. ). Lippincott Williams & Wilkins, Philadelphia, pp. 251–263.
Wrana, J. , Celeste, A. , and Attisano, L. (2003). Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol. Cell. Biol. 23, 7230–7242. , Persico, M. , Ibanez, C. , and Brivanlou, A. H. (2001). The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev. 15, 2010–2022. , and Edlund, H. (2008). Toward a renewable source of pancreatic beta-cells. Nat. Biotechnol. 26, 397–398.
S. (2003). Structures of an ActRIIB: activin A complex reveal a novel binding mode for TGF-b ligand:receptor interactions. EMBO J. 22, 1555–1566. Tsuchida, K. (2004). Activins, myostatin and related TGF-b family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr. Drug Target Immune Endocr. Metabol. Disord. 4, 157–166. , and Inokuchi, K. (2009). Activin signaling as an emerging target for therapeutic interventions. Cell Commun. Signal. 7, 15–25. Walsh, F. , and Celeste, A.